DALMASSO, BRUNA SAMIA
 Distribuzione geografica
Continente #
EU - Europa 1.945
Totale 1.945
Nazione #
IT - Italia 1.945
Totale 1.945
Città #
Genova 1.069
Rapallo 349
Genoa 285
Vado Ligure 239
Bordighera 3
Totale 1.945
Nome #
Heterogeneity and frequency of BRAF mutations in primary melanoma: Comparison between molecular methods and immunohistochemistry 178
CDKN2A germline mutations are not associated with poor survival in an Italian cohort of melanoma patients 147
Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations 135
Circulating MicroRNAs as easy-to-measure aging biomarkers in older breast cancer patients: Correlation with chronological age but not with fitness/frailty status 134
Age-related microRNAs in older breast cancer patients: Biomarker potential and evolution during adjuvant chemotherapy 123
An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: Preliminary results on tolerability and clinical effects 114
The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters 108
Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide 107
Biological ageing and frailty markers in breast cancer patients 103
Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: Interplay between germline and somatic variations [Oncotarget. 2018; 9:5691-5702]doi 10.18632/oncotarget.23204 92
Disruption of DNA damage response pathways in tumorigenesis: investigating the role of ATM and BAP1 in hereditary cancers. 89
Clinical, pathological and dermoscopic phenotype of MITF p.E318K carrier cutaneous melanoma patients 74
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1 70
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 66
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 59
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia 54
Efficacy of braf and mek inhibition in patients with braf‐mutant advanced melanoma and germline cdkn2a pathogenic variants 52
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility 44
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications 43
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients 43
Factors Affecting Sentinel Node Metastasis in Thin (T1) Cutaneous Melanomas: Development and External Validation of a Predictive Nomogram 41
First international workshop of the ATM and cancer risk group (4-5 December 2019) 36
Combining germline, tissue and liquid biopsy analysis by comprehensive genomic profiling to improve the yield of actionable variants in a real-world cancer cohort 33
Reply to E. Hindié 27
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup 26
Germline pathogenic variants of cancer predisposition genes in a multicentre Italian cohort of pancreatic cancer patients 14
Totale 2.012
Categoria #
all - tutte 9.342
article - articoli 9.047
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020246 0 0 0 0 0 0 70 34 36 46 46 14
2020/2021212 11 13 11 17 9 27 6 18 21 30 29 20
2021/2022278 23 4 14 27 13 30 8 55 24 36 11 33
2022/2023406 36 42 8 46 65 48 0 39 65 2 47 8
2023/2024217 12 18 2 29 12 30 10 23 8 14 10 49
2024/2025260 16 38 19 56 75 55 1 0 0 0 0 0
Totale 2.012